[ad_1]
Medical AI firm JLK from South Korea has acquired medical gadget approval from Meals and Drug Administration Thailand for its AI mind picture evaluation answer.
Based in 2014, the startup gives a spread of picture evaluation instruments beneath its Medihub platform, which helps the prognosis of neurological and most cancers ailments. It additionally operates different AI-powered platforms for telehealth, medical genomics, and knowledge administration, which all join to at least one cloud system.
WHAT IT DOES
JLK’s Atroscan makes use of AI to categorise and divide a 3D mind MRI picture into 62 areas and measure the thickness of the mind’s cortex and diploma of mind atrophy. These outcomes point out a affected person’s stage of mind ageing, which the software program may also evaluate to the common of their similar age group. Its different functionalities embrace personalised stories and monitoring evaluation and administration.
WHY IT MATTERS
With its current clearance, JLK continues its enlargement in Thailand with a concentrate on providing its AI options for mind and lung ailments, which often happen among the many senior inhabitants. Thailand has a quickly ageing inhabitants with the variety of its aged aged 65 and above accounting for about 13.5% of its whole inhabitants final 12 months.
Final 12 months, the corporate obtained the identical license from FDA Thailand for JViewer-X, a lung illness evaluation answer, and one other in Could this 12 months for its stroke evaluation answer Medihub Mind Aneurysm JBA-01K.
“We are going to speed up our entry into the Thai market – the main medical market in Southeast Asia – by way of the [FDA’s] approval of Atroscan, which can be utilized for the evaluation of degenerative mind ailments like dementia,” mentioned JLK CEO Dongmin Kim.
MARKET SNAPSHOT
South Korean medical AI builders are more and more focusing on Thailand, which medical gadget market is the seventh largest in Asia-Pacific. Final month, Lunit introduced that it partnered with Fujifilm Thailand to deploy its INSIGHT CXR and INSIGHT MMG software program on the Bumrungrad Worldwide Hospital. In June, FDA Thailand authorised VUNO’s software to market its AI-based VUNO Med-Chest X-ray answer within the nation.
In different dementia-related information, Fujifilm has give you a brand new AI instrument that may predict Alzheimer’s disease progression amongst sufferers with delicate cognitive impairment.
[ad_2]
Source link
